CIK 0000920148
- Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 992588107
- Phone
- +1 336-229-1127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,241,708
- in 3 filings, $108K under 10b5-1 plans
Net −$1,241,708. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | EISENBERG GLENN A Executive Vice President | Sale | −11,711 | $240.43 | $2.8M | 31,289 |
| 2024-12-02 | EISENBERG GLENN A Executive Vice President | Option exercise · Non-qualified Stock Options | −8,923 | 0 | ||
| 2024-12-02 | EISENBERG GLENN A Executive Vice President | Option exercise · Non-qualified Stock Options | −2,788 | 5,577 | ||
| 2024-12-02 | Gilliland Dwight Gary Director | Sale | −1,000 | $241.00 | $241K | 7,712 |
| 2024-11-22 | Summy Amy B. EVP, Chief Marketing Officer | Option exercise | +4,015 | $168.52 | $677K | 7,990 |
| 2024-11-22 | Summy Amy B. EVP, Chief Marketing Officer | Sale | −3,671.5 | $238.91 | $877K | 4,318.5 |
| 2024-11-22 | Summy Amy B. EVP, Chief Marketing Officer | Option exercise · Non-qualified Stock Options | −4,015 | 0 | ||
| 2024-11-21 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale | −1,000 | $239.42 | $239K | 2,669.85 |
| 2024-11-11 | Schechter Adam H President & CEO | Sale 10b5-1 | −6,189 | $243.47 | $1.5M | 87,441 |
| 2024-11-01 | Oyegunwa Akinbolade EVP, CIO & CTO | Grant or award · Restricted Stock Unit | +1,110 | 2,082 | ||
| 2024-11-01 | Bailey Megan D. EVP, Pres, Central Labs & Intl | Grant or award · Restricted Stock Unit | +1,110 | 6,517 | ||
| 2024-10-24 | ANDERSON KERRII B Director | Sale 10b5-1 | −1,000 | $230.00 | $230K | 13,722 |
| 2024-08-19 | van der Vaart Sandra D EVP, Chief Legal Officer | Sale | −2,000 | $227.05 | $454K | 3,669.85 |
| 2024-08-15 | EISENBERG GLENN A Chief Financial Officer, EVP | Sale | −2,979 | $222.65 | $663K | 43,310 |
| 2024-08-15 | EISENBERG GLENN A Chief Financial Officer, EVP | Sale | −2,950 | $223.62 | $660K | 40,360 |
| 2024-08-15 | EISENBERG GLENN A Chief Financial Officer, EVP | Sale | −9,071 | $224.55 | $2.0M | 31,289 |
| 2024-08-08 | ANDERSON KERRII B Director | Sale 10b5-1 | −586 | $225.00 | $132K | 14,722 |
| 2024-08-07 | ANDERSON KERRII B Director | Sale 10b5-1 | −414 | $225.00 | $93K | 15,308 |
| 2024-08-05 | BERBERIAN LANCE EVP, CIO & CTO | Sale | −2,245 | $229.79 | $516K | 25,769 |
| 2024-08-05 | BERBERIAN LANCE EVP, CIO & CTO | Sale | −9,848 | $228.95 | $2.3M | 15,921 |
Page 24 of 28 · 545 trades